Debra Dursobumpus - Chief People Officer, Blueprint Medicines Corp

As of September 27, 2021


Debra Dursobumpus Net Worth

  • Net worth is estimated to be at least $2.7M
  • Owns at least 30,874 units of Blueprint Medicines Corp stock
  • Sold an estimated value of $805.76K in the last year at Blueprint Medicines Corp

Debra Dursobumpus Trading

  • Largest purchase of shares was 2,300 units , worth over $82.92K on June 24, 2020
  • Largest sale of shares was 2,500 units , worth over $187.95K on June 22, 2020
  • In total has made about 8 transactions over a year
  • Usually trades in March, with the busiest year in 2020
Ticker
Type
Value
Price per Share
Shares
Filing Date
No matching records found
1

Debra Dursobumpus Mailing Address

  • Mailing address is C/o Blueprint Medicines Cororation 45 Sidney Street Cambridge MA 02139 MA

Blueprint Medicines Corp Executive Compensation

Name
Year
Salary
Total
Jeffrey W. Albers 2020 $645,000 $6,344,667
Jeffrey W. Albers 2019 $590,000 $9,362,371
Jeffrey W. Albers 2018 $541,144 $9,740,799
Michael Landsittel 2020 $379,575 $2,014,974
Michael Landsittel 2019 $345,000 $1,958,720
Michael Landsittel 2018 $281,678 $1,740,610
Fouad Namouni, M.D. 2020 $186,154 $6,668,732
Fouad Namouni, M.D. 2019 - -
Fouad Namouni, M.D. 2018 - -
Kathryn Haviland 2020 $460,944 $2,363,556
Kathryn Haviland 2019 $431,830 $3,090,423
Kathryn Haviland 2018 $392,589 $2,601,762
Tracey L. McCain, Esq. 2020 $453,301 $2,346,428
Tracey L. McCain, Esq. 2019 $437,972 $2,900,568
Tracey L. McCain, Esq. 2018 $425,216 $2,647,962
No matching records found

Source: https://www.sec.gov/Archives/edgar/data/1597264/000155837021004557/tmb-20210602xdef14a.htm

Blueprint Medicines Corp Insider Trading

  • The most recent transaction was 729 units sold on October 19, 2021 by Becker Hewes worth over $74.84K
  • In the last 6 years, insiders at Blueprint Medicines Corp sold an estimated value of $157.85M and bought an estimated value of $14.98M
  • The most active traders are Jeffrey Albers, CEO and President,  Kate Haviland, Chief Operating Officer,  and Ariel Hurley, Principal Accounting Officer
  • Insider trading is most common in June, with the busiest year in 2020

Blueprint Medicines Corp Insider Trades

Insider Names
Type
Value
Price per Share
Shares
Filing Date
No matching records found
1